Data Collection
OtherCollection of Android smartphone usage
NCT Number: NCT07826975
Alzheimer's disease is the leading cause of dementia worldwide. The first cognitive function to be affected is memory. As the disease progresses, other cognitive systems are affected, leading to a gradual loss of independence for the patient. This loss of independence is at the heart of the psychosocial and medico-economic challenges posed by Alzheimer's disease. Functional independence refers to the patient's ability to perform activities of daily living. The evolution of autonomy varies significantly from one individual to another, and a specific, personalized assessment is necessary in order to offer appropriate care and services. There is a link between patient autonomy and psycho-behavioral disorders. Early identification of loss of autonomy in connection with psycho-behavioral disorders would allow specific treatment to be put in place.
The study hypothesis is that there is a link between changes in smartphone data and changes in the independence of patients with AD.
Trial opening soon.
Get Notified60 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collection of Android smartphone usage
MMSE, FCSRT, FAB, TMT, verbal fluency test, Rey figure, BBEP, langage assesments and HAD scale
IADL Amsterdam assessed by the caregiver
Time frame: From enrollment to the end of participation at 18 months
To measure the relationship between variations in smartphone usage data-represented as a single parameter created through a mathematical combination-and variations in the Amsterdam IADL questionnaire between 0 and 18 months.
Contact information is provided by the study sponsor or research team.
Poitiers University Hospital
Other
Acronym: AUMASMART
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07142278
Alzheimer Disease, Alzheimer Disease (AD)
Miami Lakes, Florida, United States
View Trial DetailsNCT07639645
Alzheimer Disease, Alzheimer Disease (AD)
Valencia, Spain
View Trial DetailsNCT07646054
Alzheimer Disease, Alzheimer Disease (AD)
La Jolla, California, United States
View Trial DetailsNCT07611357
Alzheimer Disease, Alzheimer Disease (AD)
View Trial Details